Nessan Bermingham's Net Worth
$18.2 Million
Who is Nessan Bermingham?
Nessan Bermingham has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include Intellia Therapeutics, Inc., F-star Therapeutics, Inc., and Korro Bio, Inc..
SEC CIK
Nessan Bermingham's CIK is 0001377759
Past Insider Trading and Trends
2017 was Nessan Bermingham's most active year for acquiring shares with 3 total transactions. Nessan Bermingham's most active month to acquire stocks was the month of October. 2017 was Nessan Bermingham's most active year for disposing of shares, totalling 5 transactions. Nessan Bermingham's most active month to dispose stocks was the month of February. 2017 saw Nessan Bermingham paying a total of $100,379.16 for 570,900 shares, this is the most they've acquired in one year. In 2017 Nessan Bermingham cashed out on 336,783 shares for a total of $7,000,019.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| -42.36% | -336.78K |
$20.78 | -$7,000,019.24 | 458.25K |
Scheduled
|
Dec 6 - Dec 8
| ||
Form 4
| +1.07% | 8.4K |
$11.95 | $100,379.16 | 795.03K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +125.00% | 437.02K |
—
|
—
| 786.63K |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
F-star Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -103.88K |
$7.12 | -$739,590.00 |
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4/A
|
∞
| 16.88K |
—
|
—
| 16.88K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +515.56% | 87K |
—
|
—
| 103.88K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Korro Bio, Inc. (KRRO) Snapshot price: $42.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 35.11K |
—
|
—
| 35.11K |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |